Zhen Li

CIK 1729510 · View on SEC EDGAR ↗

Insider

First SEC filing: Jan. 29, 2018 · Latest: Jan. 29, 2018

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 1 non-open-market transaction below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

1 other filing hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Jan. 14, 2019 ARWR S 10b5-1 40,500 $14.34 $580,770 201,700 Direct -16.72% Disposed 518.6% (price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Initial ownership (Form 3) 4 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Jan. 29, 2018 ARWR Common Stock — Direct
Jan. 29, 2018 ARWR Stock Option→ Common Stock (60,000) 60,000 Direct
Jan. 29, 2018 ARWR Stock Option→ Common Stock (47,500) 47,500 Direct
Jan. 29, 2018 ARWR Stock Option→ Common Stock (50,000) 50,000 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

ARWR

President, Chemistry and Non-Clinical Development
Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2017 $247,448 — — — $120,000 — $6,798 $505,996
2016 $237,930 — — — $72,072 — $10,173 $550,654

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.